Citation

Eagle L, Rose LC, Kitchen PJ, Hawkins J. J. Consum. Policy 2005; 28(4): 433-460.

Affiliation

Middlesex Univ. Business School, The Burroughs Hendon, London, England; Dept of Commerce, Massey University (Auckland), New Zealand; University of Hull, Hull, UK (l.eagle@mdx.ac.uk)

Copyright

(Copyright © 2005, Holtzbrinck Springer Nature Publishing Group)

DOI

10.1007/s10603-005-3314-8

PMID

unavailable

Abstract

The regulatory effectiveness, the impact on industry and consumers of product withdrawal and the associated wider issues relating to crisis management represent an under-researched area. The authors describe the mid-2003 government-ordered withdrawal of almost 2,000 complementary and alternative medicines, across multiple brand names, in Australia and New Zealand. The report is based on an examination of the media coverage of the event and on interviews with key informants in manufacturing and retailing and the regulatory system. This massive, multi-brand recall provides an opportunity to examine the effectiveness and efficiency of the management of a cross-border withdrawal from regulatory and consumer policy perspectives and makes recommendations for the management of future recall events.